"Herpesvirus 4, Human" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies.
MeSH Number(s)
B04.280.382.400.500.450
B04.909.204.210.400.500.400
B04.909.204.382.400.500.400
B04.909.574.204.500.500.400
Concept/Terms
Herpesvirus 4, Human- Herpesvirus 4, Human
- Burkitt Lymphoma Virus
- Lymphoma Virus, Burkitt
- Burkitt's Lymphoma Virus
- Burkitts Lymphoma Virus
- E-B Virus
- E B Virus
- E-B Viruses
- Infectious Mononucleosis Virus
- Infectious Mononucleosis Viruses
- Mononucleosis Virus, Infectious
- Mononucleosis Viruses, Infectious
- Epstein-Barr Virus
- Epstein Barr Virus
- Herpesvirus 4 (gamma), Human
- HHV-4
- Human Herpesvirus 4
- Burkitt Herpesvirus
- Herpesvirus, Burkitt
- EBV
Below are MeSH descriptors whose meaning is more general than "Herpesvirus 4, Human".
Below are MeSH descriptors whose meaning is more specific than "Herpesvirus 4, Human".
This graph shows the total number of publications written about "Herpesvirus 4, Human" by people in Harvard Catalyst Profiles by year, and whether "Herpesvirus 4, Human" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 7 | 6 | 13 |
| 1995 | 4 | 6 | 10 |
| 1996 | 10 | 3 | 13 |
| 1997 | 7 | 4 | 11 |
| 1998 | 7 | 6 | 13 |
| 1999 | 9 | 6 | 15 |
| 2000 | 11 | 7 | 18 |
| 2001 | 8 | 10 | 18 |
| 2002 | 6 | 7 | 13 |
| 2003 | 11 | 5 | 16 |
| 2004 | 12 | 6 | 18 |
| 2005 | 7 | 6 | 13 |
| 2006 | 6 | 6 | 12 |
| 2007 | 8 | 5 | 13 |
| 2008 | 8 | 3 | 11 |
| 2009 | 8 | 12 | 20 |
| 2010 | 4 | 9 | 13 |
| 2011 | 11 | 7 | 18 |
| 2012 | 10 | 14 | 24 |
| 2013 | 9 | 11 | 20 |
| 2014 | 10 | 7 | 17 |
| 2015 | 13 | 3 | 16 |
| 2016 | 7 | 3 | 10 |
| 2017 | 9 | 10 | 19 |
| 2018 | 9 | 8 | 17 |
| 2019 | 12 | 12 | 24 |
| 2020 | 15 | 10 | 25 |
| 2021 | 8 | 20 | 28 |
| 2022 | 10 | 27 | 37 |
| 2023 | 7 | 19 | 26 |
| 2024 | 1 | 10 | 11 |
Below are the most recent publications written about "Herpesvirus 4, Human" by people in Profiles.
-
Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome. BMC Genomics. 2024 Mar 12; 25(1):273.
-
Revisiting TNM staging for EBV-related nasopharyngeal carcinoma. Cancer Cell. 2024 Mar 11; 42(3):333-334.
-
Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosis. Mult Scler. 2024 Mar; 30(3):308-315.
-
Precise CRISPR-Cas9 gene repair in autologous memory T cells to treat familial hemophagocytic lymphohistiocytosis. Sci Immunol. 2024 Feb 02; 9(92):eadi0042.
-
Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial. Lancet Oncol. 2024 Mar; 25(3):376-387.
-
In the era of antiviral trials for MS, the answer lies in the details. Mult Scler Relat Disord. 2024 02; 82:105444.
-
Virus-specific T-cells from third party or transplant donors for treatment of EBV lymphoproliferative diseases arising post hematopoietic cell or solid organ transplantation. Front Immunol. 2023; 14:1290059.
-
Host genetic variants, Epstein-Barr virus subtypes, and the risk of nasopharyngeal carcinoma: Assessment of interaction and mediation. Cell Genom. 2024 Feb 14; 4(2):100474.
-
Antiviral therapy with tenofovir in MS. Mult Scler Relat Disord. 2024 Mar; 83:105436.
-
Human leukocyte antigen-DQA1*04:01 and rs2040406 variants are associated with elevated risk of childhood Burkitt lymphoma. Commun Biol. 2024 01 05; 7(1):41.